Cubist Systematic Strategies’s Outset Medical OM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-30,303
Closed -$582K 3393
2025
Q2
$582K Buy
+30,303
New +$473K ﹤0.01% 2193
2024
Q3
Sell
-13,396
Closed -$774K 3354
2024
Q2
$774K Buy
13,396
+9,316
+228% +$456K 0.01% 1902
2024
Q1
$136K Buy
4,080
+152
+4% +$7.7K ﹤0.01% 3198
2023
Q4
$319K Sell
3,928
-1,081
-22% -$88K ﹤0.01% 2766
2023
Q3
$817K Buy
5,009
+2,979
+147% +$703K 0.01% 2017
2023
Q2
$666K Sell
2,030
-4,892
-71% -$1.49M ﹤0.01% 2219
2023
Q1
$1.91M Buy
+6,922
New +$2.54M 0.01% 1702
2022
Q4
Sell
-7,874
Closed -$1.88M 4500
2022
Q3
$1.88M Sell
7,874
-2,475
-24% -$663K 0.01% 2072
2022
Q2
$2.31M Buy
10,349
+8,731
+540% +$3.76M 0.01% 1716
2022
Q1
$1.1M Buy
1,618
+990
+158% +$596K 0.01% 1957
2021
Q4
$434K Sell
628
-817
-57% -$604K ﹤0.01% 2547
2021
Q3
$1.07M Sell
1,445
-877
-38% -$598K 0.01% 1464
2021
Q2
$1.74M Buy
+2,322
New +$1.77M 0.02% 1169
2021
Q1
Sell
-306
Closed -$261K 2937
2020
Q4
$261K Buy
+306
New +$236K ﹤0.01% 2107

Other funds holding OM

Cubist Systematic Strategies's OM Position: Q3 2025 in Review

Cubist Systematic Strategies sold out of Outset Medical (OM) in Q3 2025, closing a stake of 30,303 shares — an estimated $582K sold.

Cubist Systematic Strategies first reported a position in OM in Q4 2020 and held it in 14 quarters. The position peaked at $2.31M in Q2 2022. 101 funds tracked by Wall St. Rank hold OM as of Q3 2025.

  • Cubist Systematic Strategies reported no remaining Outset Medical position as of Q3 2025 after selling out during the quarter.
  • Cubist Systematic Strategies sold 30,303 Outset Medical shares in Q3 2025, an estimated $582K.
  • Cubist Systematic Strategies first reported a position in Outset Medical in Q4 2020 and held it in 14 quarters.
  • Cubist Systematic Strategies's Outset Medical position peaked at $2.31M in Q2 2022.
  • 101 funds tracked by Wall St. Rank held Outset Medical as of Q3 2025.

Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.